Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer

Prostate-specific membrane antigen (PSMA) represents a promising target for PSMA-overexpressing diseases, especially prostate cancer-a common type of cancer among men worldwide. In response to the challenges in tackling prostate cancers, several promising PSMA inhibitors from a variety of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritawidya, Rien, Wongso, Hendris, Effendi, Nurmaya, Pujiyanto, Anung, Lestari, Wening, Setiawan, Herlan, Humani, Titis Sekar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676551/
https://www.ncbi.nlm.nih.gov/pubmed/38022814
http://dx.doi.org/10.34172/apb.2023.079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676551/
https://www.ncbi.nlm.nih.gov/pubmed/38022814
http://dx.doi.org/10.34172/apb.2023.079

Ejemplares similares